What's new

Human medicines European public assessment report (EPAR): Loqtorzi, Toripalimab, Date of authorisation: 19/09/2024, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR): Loqtorzi, Toripalimab, Date of authorisation: 19/09/2024, Revision: 1, Status: Authorised

Apr 8, 2025 - 16:40
 0
Human medicines European public assessment report (EPAR): Loqtorzi, Toripalimab, Date of authorisation: 19/09/2024, Revision: 1, Status: Authorised
Human medicines European public assessment report (EPAR): Loqtorzi, Toripalimab, Date of authorisation: 19/09/2024, Revision: 1, Status: Authorised
Read More

Tags:

Previous Article

Nexteer expands portfolio with High Output Column-Assist Electric Power Steering

Next Article

Oil Executives Refrain From Publicly Criticizing Trump or His Tariffs

Related Posts

Human medicines European public assessment report (EPAR): Apretude, cabotegravir, Date of authorisation: 15/09/2023, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 19, 2025  0

Opinion/decision on a Paediatric investigation plan (PIP): Olumiant, Baricitinib, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Immune system disorders, PIP number: P/0520/2023

Opinion/decision on a Paediatric investigation plan (PI...

Feb 14, 2025  0

Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 7-10 April 2025

Meeting highlights from the Pharmacovigilance Risk Asse...

Apr 11, 2025  0